Oral supplementation of branched-chain amino acids reduces early recurrence after hepatic resection in patients with hepatocellular carcinoma: a prospective study
- 729 Downloads
The long-term outcomes of branched-chain amino acids (BCAA) administration after hepatic resection in patients with hepatocellular carcinoma (HCC) remain unclear. This study assessed the effect of oral supplementation with BCAA on the development of liver tumorigenesis after hepatic resection in HCC patients.
Fifty-six patients were randomly assigned to receive either BCAA supplementation (Livact group, n = 26) or a conventional diet (Control group, n = 30). Twenty-six patients in the BCAA group were treated orally for 2 weeks before and 6 months after hepatic resection. Postoperative tumor recurrence was continuously evaluated in all patients by measuring various clinical parameters.
There was no significant difference in the overall survival rate between the two patient groups; however, the recurrence rate at 30 months after surgery was significantly better in the Livact group in comparison to the Control group. Interestingly, the tumor markers, such as AFP and PIVKA-II, significantly decreased at 36 months after liver resection in the Livact group in comparison to the Control group.
Oral supplementation of BCAA reduces early recurrence after hepatic resection in patients with HCC. This treatment regimen offers potential benefits for clinical use in such patients, even in cases with a well-preserved preoperative liver function.
KeywordsBranched-chain amino acids Tumorigenesis Liver cancer Hepatectomy Nutrition
Supported by the Ministry of Education, Culture, Sports, Science, and Technology, and the Kochi University Discretionary Fund.
Conflict of interest
All authors have no conflicts of interest to declare.
- 2.Richter S, Kollmar O, Schuld J, Moussavian MR, Igna D. Chirurgische Arbeitsgemeinschaft OP-Technik und OP-Strukturen (CAOP) of the Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie. Randomized clinical trial of efficacy and costs of three dissection devices in liver resection. Br J Surg. 2009;96:593–601.PubMedCrossRefGoogle Scholar
- 5.Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Namikawa T, Maeda H, et al. Preoperative oral supplementation with carbohydrate and branched-chain amino acid-enriched nutrient improves insulin resistance in patients undergoing a hepatectomy: a randomized clinical trial using an artificial pancreas. Amino Acids. 2010;38:901–7.PubMedCrossRefGoogle Scholar
- 8.Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, for the Long-Term Survival Study (LOTUS) Group, et al. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res. 2006;35:204–14.PubMedGoogle Scholar